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Abstract
Background: Equipment used by people who inject drugs (PWID) either has a needle which is fixed to the syringe
or can be detached and replaced. Detachable low dead space syringes (LDSS) have been developed, with less space
between the needle and plunger (referred to as dead space) than traditional detachable equipment. This equipment can
help protect PWID from harm of infection as less blood is transferred if equipment is shared. Our previous research found
that detachable LDSS are likely to be acceptable to PWID, and we produced recommendations for their introduction in
needle and syringe programmes (NSP) in the United Kingdom (UK). We held a national stakeholder meeting to discuss
how to accelerate the pace and scale of the rollout and uptake of detachable LDSS. This commentary reflects on the
involvement of PWID as co-designers of harm reduction materials to implement these research findings in a way that
supports the uptake of LDSS equipment by NSP and service users. We present the user-centred design process, peer
reflections on the project, and lessons learnt by the team working with the peers.
Main body: Peers and stakeholders translated the research into easy to understand messages following a consultation
with NSP across the UK. Working with Linnell Publications over three workshops, peers selected their preferred design
style and informed the language, messages, and overall look of the designs. The peers ensured the designs avoided
images and language with negative connotations, humour, and unequivocal language. Peers said that they found the
process enjoyable and informative—leading to increased awareness of harm reduction practices. The facilitators took
steps to ensure the views of the peers were heard throughout. They reflected on the importance of involving PWID
meaningfully throughout the project. Without the peers, the designs would be less effective and engaging to their
target audience.
Conclusion: We conclude that placing peers at the heart of this research implementation project was essential to ensure
the materials are appropriate and engaging and do not stigmatise or alienate the intended audience unintentionally. We
recommend that others planning similar work include peers within the entire project to support their meaningful
contribution.
Keywords: Low dead space syringes, People who inject drugs, Harm reduction, Peers, Co-design, Involvement, Needle
and syringe programmes
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Background
Why is low dead space equipment important?
Injecting equipment used by people who inject drugs
(PWID) either has a needle which is fixed to the syringe or
can be detached and replaced. New needles should be used
for each injection to ensure they are sharp and sterile. De-
tachable, longer needles are needed for groin injecting [1].
Changing needles is also important if they become blunt or
blocked [1] and when distributing drugs between people [2].
Injecting equipment contains either low or high amounts
of ‘dead space’ between the needle and plunger, hereafter
referred to as low dead space syringes (LDSS) and high
dead space syringes (HDSS). HDSS transfer more blood if
re-used [1, 3]. Blood-borne viruses (BBVs), such as Hepa-
titis C virus (HCV) [4] and human immunodeficiency virus
(HIV) [5], survive longer in HDSS than LDSS [4], and the
risk of passing these BBVs between people is hypothesised
to be higher in HDSS compared to LDSS [5, 6].
In 2016, Exchange Supplies, a social enterprise that
supplies injecting equipment, information, and services
for PWID, developed the Total Dose dose range of de-
tachable low dead space needles, which significantly re-
duced the dead space compared to standard detachable
needle/syringe combinations [7]. The replacement of
equivalent detachable HDSS has the potential to increase
the availability of LDSS and reduce the risk of passing
viruses if the equipment is shared [5, 6, 8–12].
Our research, conducted in Bristol and Bath, found that
detachable LDSS are likely to be acceptable to PWID and
we produced recommendations for their introduction in
needle and syringe programmes (NSP) in the United King-
dom (UK) [13]. NSP are a key intervention for preventing
BBVs among PWID, providing sterile injecting equipment
and harm reduction advice. Sixty-one per cent of PWID in
England, Northern Ireland, and Wales and 73% in Scotland
report adequate needle and syringe provision (defined as
the number of needles and syringes meeting or exceeding
the number injections) [14]. While in Bristol, 57% of PWID
have ‘high’ NSP coverage [15]. In 2011, estimates of the
population of PWID in Bristol were 2295 (2025–2564)
[15], compared to 93,401 (90,974–96,757) in England [16].
At the time of this project, although detachable LDSS
were available and had been rolled out in Wales, the uptake
of the product by NSP elsewhere in the UK was at an early
stage, with only a relatively small number of early adopters
using them. Therefore, there was a need to support the im-
plementation (‘systematic efforts to encourage adoption’
p21 [17]) of this equipment using information materials in
line with the recommendations of our research.
Implementing and co-producing research
The challenge of translating health research evidence into
practice is well recognised [18, 19]. Utilising implementa-
tion science methods, the ‘how to’ or strategies used to
change practice [20] can support the successful uptake of
evidence and improvement in health outcomes [21].
Implementation strategies can include policy changes,
educating key stakeholders or champions who can bring
about change, and engagement with service users and
patients [21]. These strategies must support ‘context
sensitive’ intervention scale-up [22, 23]. One approach to
implementation is co-production which has been defined
as ‘an approach in which researchers, practitioners, and
the public work together, sharing power and responsibility
from the start to the end of the project, including the
generation of knowledge’(p4) [24]. The central tenets of
co-production are the ‘Sharing of power’, ‘Including all per-
spectives and skills’, ‘Respecting and valuing the knowledge
of all those working together on the research’, ‘Reciprocity’,
and ‘Building and maintaining relationships’ [24]. Mean-
ingful co-production requires an understanding of differ-
ent stakeholder agendas, roles, and motivation [19]. Such
understanding takes time and effort to develop and
sustain [19]. Co-production and implementation are often
adaptive, iterative, and reflective in nature [22, 23]. Under-
lying the co-production approach is an assumption that
those most affected by research, in this case PWID and
those who work with them, have the right skills and
knowledge to design and deliver it [24].
In this commentary, we present a co-production project
designed to implement our research findings [13] to
support the uptake and use of LDSS by co-designing harm
reduction materials with PWID. We describe a national
stakeholder meeting, the user-centred design process, peer
reflections on the project and lessons learnt by the team
working with the peers. ‘Peers’ refers to NSP service users
who the materials are aimed at. This commentary has
been co-written with three of the five peers.
Main body
Methods
User-centred design process
We followed a flexible and iterative user-centred design
process (Fig. 1) [25] in which we (1) identified the need for
the information materials through our research (described
above), (2) specified the context of use (identifying the
audience for the materials), (3) specified the requirements
of NSP and PWID in different contexts, (4) created design
solutions with co-designers (or peers) to meet the needs of
the target audience, and (5) evaluated and refined the de-
signs with co-designers until they satisfied their needs.
Specifying context We held a national meeting to
discuss how we can accelerate the pace and scale of the
rollout and uptake of detachable LDSS via NSP [26].
The meeting aimed to identify the key messages to be
translated into communication materials and develop
strategies to support fast implementation.
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Before the event, we ran two discussion groups with
Bristol Drugs Project (BDP) service users who had used
detachable LDSS, and staff and volunteers working in
NSP. We wanted to find out their experiences of the
new equipment, recommendations for implementation,
and suggestions for the content of communication mate-
rials to encourage the use of detachable LDSS. One of
the service users, a BDP assertive engagement worker
and National Institute for Health Research (NIHR)
CLAHRC West’s Patient and Public Involvement Facili-
tator presented the feedback from the service user group
at the stakeholder event. This process is in line with
‘planning and executing interventions’ (p20) capable of
overcoming barriers to implementation described within
the ‘Knowledge to Action Process’ [17].
We seconded an assertive engagement worker from
BDP to the project; their specialist expertise and connec-
tions were vital to this project’s success. We felt it was
important to involve PWID as co-designers of these
harm reduction materials, to ensure they are relevant
and appropriate.
Specifying requirements Next, we ran a consultation
process with eight NSP across the UK to understand
barriers to the uptake of LDSS, and how different pro-
grammes operate and share harm reduction messages.
This was to ensure that the materials would be useable
in different NSP contexts and that the messages would
be relevant. Graham and colleagues refer to this process
as adapting the knowledge or research to the local con-
text to ensure its appropriateness [17].
Most NSP visits were facilitated by our collaborators
from Exchange Supplies who emailed invitations to NSP in
a range of geographical areas with varying experiences of
detachable LDSS. DB conducted all consultations and JK
attended two. Consultations were mostly conducted face-
to-face with one or a group of staff operating the NSP
(apart from one which had to be carried out by phone due
to poor weather conditions). A semi-structured topic guide
was followed covering an overview of the NSP (e.g. opening
hours, staff number, how the NSP operates), service user
characteristics, key issues for services in this geographical
area with this client group, harm reduction information
provision to service users (e.g. what and how information is
provided, what works well/less well), if and how detachable
LDSS had been introduced and received, and feedback on
the first draft of content for the materials. This informed a
second draft of the content for the materials, which was
itself developed from the original research and stakeholder
event.
Produce design solutions and evaluate designs We
produced a design brief and invited proposals from de-
signers. We selected Michael Linnell of Linnell Publications
[27], an experienced designer specialising in harm reduction.
Five peers (three men and two women) known to BDP
staff were invited to take part in the project. We looked
for people who were likely to be willing and confident to
express their views in a group setting. We tried to ensure
Fig. 1 User-centred design process. Adapted from https://www.usability.gov/what-and-why/user-centered-design.html. Diagram displaying the
user-centred design process followed in the project
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the group was diverse in terms of gender, injecting experi-
ences, attitude to detachable LDSS, and awareness of a
wide range of harm reduction information and materials.
However, the group was not ethnically diverse. One of the
peers had attended the national stakeholder meeting (see
above). Their involvement throughout the project was
valuable as they had insight into its development and were
able to share this experience with the other peers. All
peers were paid with high street shopping vouchers for
their input, following INVOLVE guidance [28].
We held three workshops to design the materials. In
the first workshop, the peers selected their preferred
design style from a range of options (Fig. 2). We then
discussed their preferences for the tone of the materials,
use of language and imagery, and use of corporate
branding and content. In the second workshop, they
were shown the first draft designs (Fig. 3) and asked to
comment on the language, messages, and overall look
and feel. The final workshop was an opportunity for
peers to feedback on all the designs before they were
finalised (Fig. 4).
A fourth reflective discussion workshop was held to re-
flect on peers’ and project facilitators’ (researcher, assertive
engagement worker, and communications manager) experi-
ence of the project. In this group we posed the following
questions to each other:
– What did peers see as their role in the project?
– What did peers get out of and learn from
involvement in the project?
– What did the facilitators do that the peers liked/
disliked?
– What have the facilitators learnt from involving
peers in the project?
Detailed notes were taken by JK and ZTW at each work-
shop, incorporating all feedback, including contradictory
points, and fed back to the designer—who was present at
the final two of the three design sessions. We present a
summary of the key reflections from each phase below.
Reflections
National stakeholder meeting
Twenty stakeholders, including staff and service users from
NSP, injecting equipment manufacturers, local authorities,
commissioners, Public Health England, PWID, and
academics, attended the meeting. These stakeholders
discussed the intended audience and key messages and
what could be achieved by producing a video and other
communication materials. The stakeholders suggested that
information materials with some animated content would
be more appropriate than a video to reach service users
who are the primary audience for these materials. Staff and
volunteers working in NSP and commissioners are second-
ary audiences.
The group agreed that the content should go further
than simply encouraging the use of detachable LDSS, by
promoting broader injecting harm reduction messages.
The stakeholders agreed the following topics to cover:
1. Needle and syringe programme benefit
2. Equipment choice
3. Safer injecting practices
4. Encouraging the return of used equipment
5. Low dead space needles
6. Rinsing and sterilising equipment
NSP consultation
The NSP visited varied in terms of if and when detachable
LDSS had been introduced, number of service users, num-
ber of staff, and size of city or town. The common issues
they faced included the following:
 Service users being in a rush, so giving harm
reduction advice was challenging;
 High use of pharmacy NSP, where less harm
reduction advice was provided, rather than using
specialist services;
 Staff who do not regularly work in NSP found
providing harm reduction advice difficult;
 Low levels of equipment returns.
The response to introducing detachable LDSS varied.
Most services had completely replaced HDSS equipment
rather than phasing LDSS in gradually as recommended
by our research [13]. While some reported no issues,
others described service users requesting the old equip-
ment and initial complaints about the change.
Overall, feedback on the proposed use and content of
the information materials was positive. Key feedback in-
cluded ensuring images of equipment were generic rather
than brand specific, and including a clear explanation of
which equipment is appropriate for service user needs and
why. NSP also wanted the materials to include messages
encouraging the return of used equipment and rinsing
used equipment and messages emphasising the benefits of
using specialist NSP (rather than community pharmacy)
including confidentiality, continuity of staff, and the ability
to build trusting relationships.
This consultation provided key insights for the next
phase of developing the materials.
Co-design workshop 1: Choosing the design styles and
considering appropriate language
Retro and unique style selected Discussing the style
sheets was revealing both in terms of the peers’
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preferences, but also what they did not like. For ex-
ample, they considered a cartoonish style patronising
and not serious enough.
The peers selected a strong retro Soviet propaganda
style (Fig. 2 styles 9 and 10) using a simple contrasting
colour palette of red, black, and cream. They chose this
style because it was unlike the style of traditional harm
reduction materials, targeted at PWID bold, bright, and
eye-catching and drew the eye to the centre of the de-
sign. Peers thought these design features would help at-
tract attention and encourage people to adopt the
practices communicated in the messages.
Avoiding stereotypical imagery Peers emphasised the
importance of avoiding images with negative connota-
tions, which could be interpreted as implying PWID are
‘disgusting’ or ‘dirty’, such as very veiny arms or shocking
images of health problems. Line or diagrammatic draw-
ings struck the right tone of being serious while not car-
rying any value judgement. The peers preferred images
of body parts, such as arms or hands, rather than whole
people. This also meant images could be gender neutral.
Similarly, the group did not like images of eyes which
give a sense of being watched, looked down on, and
judged or of pointing fingers which felt accusatory.
The peers recommended avoiding stereotypical por-
trayals of PWID (e.g. homeless people) because they
could cause offence and lead to people feeling
stigmatised or judged. The peers discussed that people
may feel disconnected from images to which they cannot
relate. Images representing a small portion of PWID
may result in people feeling the information is not
intended or useful for them.
Ensuring appropriate language and tone Peers felt it
was important to avoid unequivocal messages which tell
people what to do, especially messages about the dan-
gers of using drugs. This could be patronising, would
not be appropriate to the target audience, and could lead
to people rejecting all the messages. Universal slang
terms (e.g. ‘works’) were preferred over more generic,
factual language (e.g. equipment), but local slang should
be avoided.
The group suggested the use of humour should be
carefully considered—everyone felt that a serious tone
should be adopted and that humour had the potential to
get in the way of clear messages and trivialise a serious
topic. The peers knew people who had HCV and HIV,
and they felt that messages should reflect the seriousness
of the issues.
Content The message that the new equipment would
save the NHS (United Kingdom National Health Service
funded by the government to provide medical and health
care services) money due to reduced HCV treatment
costs [29] did not resonate with most of the peers. Most
Fig. 2 Style sheets. Eleven design style sheets created by the designer and presented to the peers in the first workshop. The peers selected style
sheets 9 and 10
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also viewed the use of NHS and NIHR (which funds
health and social care research in England) logos on ma-
terials negatively as this could imply blaming PWID for
healthcare costs. Some peers also expressed a mistrust
of the NHS, having received poor treatment and feeling
that health professionals did not care about them or
understand their experience.
Co-design workshop 2 and 3: Feedback on the designs
In response to the initial designs (Fig. 3), there was a
general preference for images without body parts. Dur-
ing the first workshop, the peers agreed that body parts
should be gender neutral. However, when they saw the
initial designs, the group felt the arm image (Fig. 3)
would be perceived to be male. One peer pointed out
that there is no such thing as a ‘gender neutral’ body
part. Even images intended to be neutral are often
interpreted as male—‘for example, female toilet signs
have skirts to indicate the gender!’, At this point, it was
agreed that it was too difficult to design body parts that
reflect everyone, and as the messages were about the
equipment, service users would make the connection
between dead space and blood without body images.
Although they acknowledged that the initial designs may
reflect some ‘truth’ or accuracy, the peers explained that
people do not want to be confronted with this and the
peers did not want to contribute to the stigmatisation of
others.
From this process, seven attractive and engaging post-
ers (Fig. 4) were produced. The first poster is designed
to inform people about dead space. The peers selected
the strapline ‘Less bugs, more drugs’ which was also one
of the key messages from the original research. The sec-
ond poster displays the dead space in the various types
Fig. 3 Initial design. One example of the first draft designs discussed in the second workshop
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of injecting equipment to help service users make an in-
formed choice about their equipment. This was the most
challenging poster to get right visually and in terms of
the language used. The next poster highlights the bene-
fits of using low dead space equipment. We designed the
poster about rinsing and sterilising to emphasise that
low dead space equipment is more effective to clean be-
cause there is less space between the needle and plunger.
This poster also provides the steps for sterilising equip-
ment and highlights the importance of cleaning LDSS
before re-using. The ‘Dead space, viruses, sharing’ poster
combines the message about choosing the lowest dead
space possible for the injection site with broader harm
reduction messages, including getting tested for BBVs,
and taking enough equipment from NSP. The ‘Take, re-
turn, repeat’ poster encourages the return of used equip-
ment to NSP. Low equipment return rates was an issue
highlighted during the visits to NSP. The last poster was
not part of our original plans. It was designed to in-
crease awareness that new low dead space needles are
incompatible with the barrels in Prenoxad kits contain-
ing naloxone. If the needles from the naloxone kit are
used to inject drugs, the kit must be returned for a
replacement. Otherwise, the kit will be useless when
people need to administer naloxone. This was highlighted
as an issue by the BDP members of our steering group.
These poster designs were also reworked into a 16-page
booklet (https://www.exchangesupplies.org/shopsect_lin-
nell_publications.php) and a series of short animations
(https://binged.it/2INd7TY), which were identified as use-
ful formats during the NSP consultation stage.
Co-design workshop 4: Peer and facilitator reflections on
the project
Co-designer role: consultant and level of anticipated
vs actual involvement One of the group commented
Fig. 4 Final designs. The seven final designs available to download
here are (https://www.exchangesupplies.org/shopsect_linnell_
publications.php): ‘Dead space—what is it?’: this poster is designed
to inform people about dead space, clearly illustrating what it is.
‘Dead space compared’: this poster shows the dead space in various
types of injecting equipment, to help service users make an
informed choice. ‘Less bugs, more drugs’: this poster displays the
benefits of using low dead space equipment. These benefits were
identified through the research. ‘Dead space, viruses, sharing’: this
poster combines the message about choosing the lowest dead
space possible for where people inject, with broader harm reduction
messages. ‘Take, return, repeat’: this poster is designed to encourage
the return of used equipment to needle and syringe programmes.
‘Be wise, sterilise’: this poster explains that rinsing low dead space
equipment is more effective and gives the steps for sterilising
equipment. ‘Naloxone saves lives’: this poster aims to encourage
naloxone use, while increasing awareness that low dead space
needles are not compatible with Prenoxad kits
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that the explanation of the project’s purpose and their
role was clear and they felt supported to attend and con-
tribute. Peers viewed themselves as consultants to the
project and liked the idea of being involved. One
co-designer initially thought their role would be more
tokenistic, expecting to be shown the materials once
they had been designed and asked to provide feedback
on them (e.g. ‘Do you understand these materials? Do you
like them?’). Rather than being ‘done’ to them, the peers
talked about feeling fully involved in the entire process.
One peer commented that most information materials
available in NSP are not really looked at because they
are too plain. They suspected they probably had not
been made by service users and did not appear to ‘have
them in mind’. By involving peers in this project, they
felt the materials were more credible as they reflected
the language used by service users and their preferences.
Positive experiences The peers enjoyed being involved
in the design process, from choosing style sheets which
best represented them to seeing the designs evolve over
time. Importantly, the peers felt their feedback was in-
corporated at every stage of the design process. For ex-
ample, the group decided on the order of the benefits of
LDSS and the language used, preferring ‘less bugs, more
drugs’ to ‘more bang for your buck’. They felt the latter
was American in tone, overly familiar and likened it to
when Google says ‘Oops!’ when it crashes—‘I’m not your
friend Google!’ Other examples were not using body part
imagery and avoiding humour.
Participants said that having their voices heard and
valued was a validating experience, contrasting with
some previous experiences of participating in research
(‘You can feel like a rat in a cage sometimes, with people
coming in to study you’).
What was learnt from involvement in the project?
Awareness of and attitude towards LDSS
Throughout the project, the group became more aware
of the concept of dead space and the benefits of using
the lowest dead space equipment possible. One person
had not liked detachable LDSS at the start of the project
and found them to be flimsier than the high dead space
equivalent. However, having spoken to the equipment
developer at the stakeholder event, they were convinced
of their benefits and made the switch. Another person
was not aware of why low dead space was important but
now understands it well and will continue to use LDSS.
Lastly, two of the group did not like LDSS because the
coloured needle hub makes it difficult to know if you are
in a vein. Participating in the group did not change their
view on this, but one of these peers felt they had learned
enough about the equipment to know that they would
be useful if their lifestyle was more chaotic and they
were more at risk of sharing equipment.
Awareness of broader harm reduction issues
Some other beneficial learning from participation in the
project included how to rinse and sterilise the equip-
ment effectively, that low dead space needles do not fit
on naloxone barrels, and that flushing damages veins. As
a result, one member talked about sterilising needles as
a new habit and two had tried to reduce the amount
they flush.
Sharing learning with others
The peers were motivated to share harm reduction mes-
sages learnt through the project with others. They spoke
to other people about the project, dead space, and
broader harm reduction messages like cleaning equip-
ment after use, not re-using, or flushing.
Practicalities
Running the group in the afternoon and payment for
their time supported engagement and was appreciated.
Group composition and dynamics
The group felt they had a good mix of experiences,
knowledge, and ages. They worked well together, were
respectful of each other, and listened to differing
opinions.
The peers felt that the designer and facilitators listened
to them and accepted their views. There was no condes-
cension or sense of being judged, and the designer and
facilitators guided and helped crystallise their ideas. The
designer had ‘no airs and graces’, his tone and body lan-
guage were engaging, and he clearly wanted to hear what
they had to say. He was not precious about his work,
and there was an understanding that everyone shared
the same goal.
What have the facilitators learnt from involving peers in
the project?
Benefits of peer involvement
All facilitators agreed that it has been invaluable and re-
warding to collaborate with peers in this work. Without
working with peers, the materials would have been very
different and likely ineffective at communicating and en-
gaging with the audience. For example, they may have
contained depictions of cartoon characters, body im-
agery, and humour all of which had the potential to stig-
matise and result in a negative response. The discussion
around body imagery and gender neutrality also high-
lights the importance of prolonged engagement with
peers because it was only by seeing the designs that the
group could determine it was not appropriate. More
broadly, this project has led to greater recognition across
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BDP of the benefit of service user involvement in service
design and delivery.
Forming equitable partnerships
The facilitators sought to create an equitable partnership
with the peers in several ways. Firstly, they placed
greater emphasis on the peers’ preferences than their
own. At the first workshop, the facilitators emphasised
that the peers were the experts and that their input
would be taken seriously.
During the workshops, the facilitators made a con-
scious effort not to interject, use closed or leading
questions, or give personal views while maintaining a
collaborative, encouraging approach. However, it was
difficult at times not to intervene or unintentionally in-
fluence the views of the co-designers as the facilitators
had spent a considerable amount of time considering
the content for the materials and were also very passion-
ate about the project.
When getting feedback from the project steering
group, the facilitators advocated for the peers. They con-
sciously kept the peers’ views in mind, emphasising and
reiterating them when necessary. In this way, the peers
were given a voice even in conversations where they
were not present.
Table 1 presents key learning outcomes from this
project.
Strengths and Limitations
This project has a number of strengths and limita-
tions that warrant consideration. We did not follow a
formal process for capturing each stage of this pro-
ject. For example, we did not formally analyse the re-
flections using a theoretical framework. Including
peers who were expected to actively engage in the
workshops may mean that the materials were not re-
flective of all service users. The group did reflect on
the anticipated views and experiences of others, in-
cluding those with less settled lifestyles. We feel that,
on balance, the group were well placed to contribute
to this project. The group was not ethnically diverse,
though this reflects the BDP service user population.
The consultation process helped ensure the content
of the materials is relevant to different NSP contexts
and our approach is in line with guidance on
co-producing research [24].
Conclusions and recommendations for future co-
design projects
As there is no single approach for performing
co-produced projects [24], this commentary serves as an
example of how research findings can be implemented
through the co-design of information materials. Placing
peers at the heart of this project was essential to ensur-
ing the materials were appropriate and engaging and
avoid unintentionally stigmatising or alienating the
intended audience. We recommend that others planning
similar work include peers in the entire project to sup-
port their meaningful contribution.
The facilitators approached the project with an open
mind and advocated for the views of the peers, whose
opinions were paramount. The professionals involved in
such projects must practice humility and be prepared to
have their views challenged, such as the use of humour
in drug harm reduction materials, which is a well-
established tradition.
Harm reduction materials that resonate with their
intended audience are more likely to influence those
people’s attitudes and behaviour. The peers’ contribution
was central to developing materials that were appealing
while treating the intended audience with respect.
Abbreviations
BBV: Blood-borne virus; BDP: Bristol Drugs Project; HCV: Hepatitis C virus;
HDSS: High dead space syringes; HIV: Human immunodeficiency virus;
Table 1 Key learning outcomes. This table presents learning outcomes and recommendations from the project
Learning outcome
topic
Description Recommendation
Stakeholder
consultation is key
The consultation process with NSP ensured the
informational materials are useable/relevant in different NSP
contexts.
Identify and be responsive to the needs and requirements of
a broad range of stakeholders.
Importance of
emphasising peers’
preferences
The facilitators emphasised that the peers were the experts
in the co-design process.
Clarify roles and form equitable partnerships at the
beginning of the project.
Need to recognise
threats to co-
production
The facilitators found it difficult at times not to intervene or
unintentionally influence the views of the co-designers.
Engage in reflective practices to recognise and overcome
threats to equitable co-production.
Necessary to give
peers’ a voice
The facilitators advocated for peer viewpoints during
meetings they did not attend.
Voice peer viewpoints when they are not present.
Flexibility and reflection This project highlights the importance of being flexible and
responsive to new insights and ideas.
Co-designed projects require flexibility in their approach to
ensure the product produced meets the end users’ needs.
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